-+ 0.00%
-+ 0.00%
-+ 0.00%

NOVO NORDISK CSO: WE WANT TO BRING ORAL AND SUBCUTANEOUS ZENAGAMTIDE TO THE MARKET SIMULTANEOUSLY

Reuters·09/21/2026 10:05:03